Different glioma cell lines and PCNSL xenografts expressed different amounts of CXCR4 (green immunostain), providing a range of expression levels for testing the CXCR4 imaging efficacy of the radiolabeled cyclam derivatives in these animal models. This evidence concerns the gene CXCR4 and central nervous system cancer.